메뉴 건너뛰기




Volumn 30, Issue 1, 2000, Pages 2-5

Global initiative for asthma (GINA) and its objectives

Author keywords

Asthma; Corticosteroids; GINA; Guidelines; Leukotriene receptor antagonists; Prevalence

Indexed keywords

CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

EID: 0034119451     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (161)

References (13)
  • 1
  • 2
    • 0028264310 scopus 로고
    • Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group
    • Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 1994; 344: 219-24.
    • (1994) Lancet , vol.344 , pp. 219-224
    • Greening, A.P.1    Ind, P.W.2    Northfield, M.3    Shaw, G.4
  • 3
    • 0033585883 scopus 로고    scopus 로고
    • Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelines
    • Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 1999; 318: 527-30.
    • (1999) BMJ , vol.318 , pp. 527-530
    • Woolf, S.H.1    Grol, R.2    Hutchinson, A.3    Eccles, M.4    Grimshaw, J.5
  • 4
    • 0033583746 scopus 로고    scopus 로고
    • Users' guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Group and the Cochrane Applicability Methods Working Group
    • Guyatt GH, Sinclair J, Cook DJ, Glasziou P. Users' guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Group and the Cochrane Applicability Methods Working Group. JAMA 1999; 281: 1836-43.
    • (1999) JAMA , vol.281 , pp. 1836-1843
    • Guyatt, G.H.1    Sinclair, J.2    Cook, D.J.3    Glasziou, P.4
  • 5
    • 0032529297 scopus 로고    scopus 로고
    • Guidelines for clinical guidelines
    • Jackson R, Feder G. Guidelines for clinical guidelines [editorial]. BMJ 1998; 317: 427-8.
    • (1998) BMJ , vol.317 , pp. 427-428
    • Jackson, R.1    Feder, G.2
  • 6
    • 0342743084 scopus 로고    scopus 로고
    • Global strategy for asthma management and prevention. WHO/ NHLBI workshop report. National Institutes of Health, National Heart, Lung and Blood Institute, Publication Number 95-3659 1995
    • Global strategy for asthma management and prevention. WHO/ NHLBI workshop report. National Institutes of Health, National Heart, Lung and Blood Institute, Publication Number 95-3659 1995.
  • 7
    • 0031912740 scopus 로고    scopus 로고
    • Airway inflammation in mild intermittent and in persistant asthma
    • Vignola AM, Chanez P, Campbell AM et al. Airway inflammation in mild intermittent and in persistant asthma. Am J Respir Crit Care Med 1998; 157:403-9.
    • (1998) Am J Respir Crit Care Med , vol.157 , pp. 403-409
    • Vignola, A.M.1    Chanez, P.2    Campbell, A.M.3
  • 10
    • 0032564163 scopus 로고    scopus 로고
    • House dust mite control measures in the management of asthma: Meta-analysis
    • Gotzsche PC, Hammarquist C, Burr M. House dust mite control measures in the management of asthma: meta-analysis. BMJ 1998; 317: 1105-10.
    • (1998) BMJ , vol.317 , pp. 1105-1110
    • Gotzsche, P.C.1    Hammarquist, C.2    Burr, M.3
  • 11
    • 0032564157 scopus 로고    scopus 로고
    • House dust mite allergen avoidance in asthma. Benefits unproved hut not yet excluded
    • Strachan DP. House dust mite allergen avoidance in asthma. Benefits unproved hut not yet excluded [editorial]. BMJ 1998; 317:1096-7.
    • (1998) BMJ , vol.317 , pp. 1096-1097
    • Strachan, D.P.1
  • 12
    • 0033608648 scopus 로고    scopus 로고
    • Control of house dust mite in managing asthma. Conclusions of meta-analysis are wrong
    • Platts-Mills TA, Chapman MD, Wheatly LM. Control of house dust mite in managing asthma. Conclusions of meta-analysis are wrong [letter; comment]. BMJ 1999; 318:870-1.
    • (1999) BMJ , vol.318 , pp. 870-871
    • Platts-Mills, T.A.1    Chapman, M.D.2    Wheatly, L.M.3
  • 13
    • 0343613032 scopus 로고    scopus 로고
    • Differences between asthma exacerbations and poor asthma control
    • 9
    • Reddel H, Ware S, Marks G, Salome C, Jenkins C, Woolcock A. Differences between asthma exacerbations and poor asthma control. Lancet 1999; 553 (364-9): 14.
    • (1999) Lancet , vol.553 , Issue.364 , pp. 14
    • Reddel, H.1    Ware, S.2    Marks, G.3    Salome, C.4    Jenkins, C.5    Woolcock, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.